These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11481973)

  • 21. [Pathophysiology of schizophrenia and its impact on pharmacotherapy].
    Widschwendter CG; Fleischhacker WW
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S32-7. PubMed ID: 16270242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brain imaging in schizophrenic psychoses].
    Martinot JL
    Encephale; 1996 Oct; 22 Spec No 3():18-24; discussion 25-6. PubMed ID: 9036005
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia.
    Li XM; Xu H
    Int Rev Neurobiol; 2007; 77():107-42. PubMed ID: 17178473
    [No Abstract]   [Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biochemistry of schizophrenia.
    Crow TJ
    Br J Hosp Med; 1978 Nov; 20(5):532, 537-44. PubMed ID: 32942
    [No Abstract]   [Full Text] [Related]  

  • 26. Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia.
    Uhlhaas PJ
    Curr Opin Neurobiol; 2013 Apr; 23(2):283-90. PubMed ID: 23228430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of schizophrenia: dopamine hypothesis.
    Neylan TC
    J Neuropsychiatry Clin Neurosci; 1996; 8(2):222. PubMed ID: 9081562
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurobiology in the neuropharmacology of antipsychotic drugs].
    Tassin JP
    Encephale; 2006 Jan; 32 Pt 2():S6-7. PubMed ID: 16800077
    [No Abstract]   [Full Text] [Related]  

  • 29. Biological underpinnings of treatment resistance in schizophrenia: an hypothesis.
    Bartzokis G; Altshuler L
    Psychopharmacol Bull; 2003; 37(4):5-7. PubMed ID: 15272475
    [No Abstract]   [Full Text] [Related]  

  • 30. The quantitative neuropathology of schizophrenia.
    Hof PR; Schmitz C
    Acta Neuropathol; 2009 Apr; 117(4):345-6. PubMed ID: 19247680
    [No Abstract]   [Full Text] [Related]  

  • 31. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary study of schizophrenics with brain atrophy treated with antipsychotic drugs].
    Wang XY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):294-6, 319. PubMed ID: 2906857
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery.
    Hajós M
    Trends Pharmacol Sci; 2006 Jul; 27(7):391-8. PubMed ID: 16766049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.
    Gogos JA
    Int Rev Neurobiol; 2007; 78():397-422. PubMed ID: 17349868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical and physiologic brain imaging in schizophrenia.
    McClure RJ; Keshavan MS; Pettegrew JW
    Psychiatr Clin North Am; 1998 Mar; 21(1):93-122. PubMed ID: 9551493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pharmacotherapy of schizophrenia.
    Lapierre YD
    Psychiatr J Univ Ott; 1983 Jun; 8(2):81-5. PubMed ID: 6137017
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.
    Tamminga CA; Burrows GH; Chase TN; Alphs LD; Thaker GK
    Ann N Y Acad Sci; 1988; 537():443-50. PubMed ID: 2904785
    [No Abstract]   [Full Text] [Related]  

  • 40. NMDA receptors and schizophrenia.
    Kristiansen LV; Huerta I; Beneyto M; Meador-Woodruff JH
    Curr Opin Pharmacol; 2007 Feb; 7(1):48-55. PubMed ID: 17097347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.